{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:49:58Z","timestamp":1788522598432,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.prro.2018.04.009","type":"journal-article","created":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T05:13:31Z","timestamp":1535692411000},"page":"307-316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Contemporary prostate cancer radiation therapy in the United States: Patterns of care and compliance with quality measures"],"prefix":"10.1016","volume":"8","author":[{"given":"Daniel J.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Barocas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ching","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Resnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Conwill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"McCollum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Cooperberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon","family":"Greenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann S.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Hashibe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherrie H.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa E.","family":"Paddock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette M.","family":"Stroup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Cheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Penson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen E.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2018.04.009_bb0005","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1377\/hlthaff.2009.0324","article-title":"Assessing the evidence for value-based insurance design","volume":"29","author":"Choudhry","year":"2010","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.prro.2018.04.009_bb0010","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1001\/jama.2010.1513","article-title":"Accountable care organizations: accountable for what, to whom, and how","volume":"304","author":"Fisher","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.prro.2018.04.009_bb0015","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1056\/NEJMsa022615","article-title":"The quality of health care delivered to adults in the United States","volume":"348","author":"McGlynn","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2018.04.009_bb0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/jamaoncol.2015.3384","article-title":"Racial differences in the surgical care of Medicare beneficiaries with localized prostate cancer","volume":"2","author":"Schmid","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.prro.2018.04.009_bb0025","doi-asserted-by":"crossref","first-page":"S562","DOI":"10.2105\/AJPH.2014.302079","article-title":"Racial disparities in cancer care in the Veterans Affairs health care system and the role of site of care","volume":"104","author":"Samuel","year":"2014","journal-title":"Am J Public Health"},{"key":"10.1016\/j.prro.2018.04.009_bb0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jnci\/djq495","article-title":"Projections of the cost of cancer care in the United States: 2010-2020","volume":"103","author":"Mariotto","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.prro.2018.04.009_bb0035","author":"Centers for Medicare and Medicaid Services"},{"key":"10.1016\/j.prro.2018.04.009_bb0040","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ijrobp.2012.08.038","article-title":"Quality indicators in radiation oncology","volume":"85","author":"Albert","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2018.04.009_bb0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.prro.2012.01.006","article-title":"Evaluation of adherence to quality measures for prostate cancer radiotherapy in the United States: Results from the Quality Research in Radiation Oncology (QRRO) survey","volume":"3","author":"Zelefsky","year":"2013","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2018.04.009_bb0050","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/1754-9485.12142","article-title":"FROGG high-risk prostate cancer workshop: Patterns of practice and literature review. Part I: Intact prostate","volume":"58","author":"Lehman","year":"2014","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.prro.2018.04.009_bb0055","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.radonc.2013.04.017","article-title":"Quality of care indicators and their related outcomes: A population-based study in prostate cancer patients treated with radiotherapy","volume":"107","author":"Webber","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2018.04.009_bb0060","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.radonc.2013.04.023","article-title":"A criterion-based audit of the technical quality of external beam radiotherapy for prostate cancer","volume":"107","author":"Brundage","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2018.04.009_bb0065","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0090-4295(96)00226-9","article-title":"The CaPSURE database: A methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor","volume":"48","author":"Lubeck","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.prro.2018.04.009_bb0070","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2217\/cer.13.34","article-title":"Using a population-based observational cohort study to address difficult comparative effectiveness research questions: The CEASAR study","volume":"2","author":"Barocas","year":"2013","journal-title":"J Comp Eff Res"},{"key":"10.1016\/j.prro.2018.04.009_bb0075","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1002\/cncr.22615","article-title":"Assessment of prognosis with the total illness burden index for prostate cancer: Aiding clinicians in treatment choice","volume":"109","author":"Litwin","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2018.04.009_bb0080","author":"National Comprehensive Cancer Network"},{"key":"10.1016\/j.prro.2018.04.009_bb0085","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.brachy.2011.07.005","article-title":"American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy","volume":"11","author":"Davis","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.prro.2018.04.009_bb0090","author":"American Brachytherapy Society"},{"key":"10.1016\/j.prro.2018.04.009_bb0095","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/MOU.0b013e3282f9b393","article-title":"Assessing the quality of prostate cancer care","volume":"18","author":"Penson","year":"2008","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.prro.2018.04.009_bb0100","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1200\/JOP.2013.001003","article-title":"Practice-based evidence to evidence-based practice: Building the National Radiation Oncology Registry","volume":"9","author":"Efstathiou","year":"2013","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.prro.2018.04.009_bb0105","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer","volume":"280","author":"D'Amico","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.prro.2018.04.009_bb0110","series-title":"Modeling Strategies with Applications to Linear Models, Logistic and Ordinal Regression and Survival Analysis","article-title":"Regression","author":"Harrell","year":"2015"},{"key":"10.1016\/j.prro.2018.04.009_bb0115","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.prro.2017.03.011","article-title":"Implementation of hypofractionated prostate radiation therapy in the United States: A National Cancer Database analysis","volume":"7","author":"Stokes","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2018.04.009_bb0120","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","article-title":"The National Cancer Data Base: A powerful initiative to improve cancer care in the United States","volume":"15","author":"Bilimoria","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.prro.2018.04.009_bb0125","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1002\/cncr.30101","article-title":"Use, complications, and costs of stereotactic body radiotherapy for localized prostate cancer","volume":"122","author":"Halpern","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2018.04.009_bb0130","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1200\/JCO.2005.05.2530","article-title":"Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy","volume":"24","author":"Peeters","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2018.04.009_bb0135","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1470-2045(07)70143-2","article-title":"Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial","volume":"8","author":"Dearnaley","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2018.04.009_bb0140","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijrobp.2007.06.054","article-title":"Long-term results of the MD Anderson randomized dose-escalation trial for prostate cancer","volume":"70","author":"Kuban","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2018.04.009_bb0145","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.294.10.1233","article-title":"Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial","volume":"294","author":"Zietman","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.prro.2018.04.009_bb0150","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1012348","article-title":"Radiotherapy and short-term androgen deprivation for localized prostate cancer","volume":"365","author":"Jones","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2018.04.009_bb0155","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1097\/01.ju.0000140159.94703.80","article-title":"Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median follow up of 5.4 years","volume":"172","author":"Wirth","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.prro.2018.04.009_bb0160","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1200\/JCO.2006.10.5171","article-title":"Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01","volume":"25","author":"Pommier","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2018.04.009_bb0165","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.ijrobp.2007.04.003","article-title":"An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: Updated analysis of RTOG 94-13, with emphasis on unexpected hormone\/radiation interactions","volume":"69","author":"Lawton","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2018.04.009_bb0170","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/0360-3016(88)90225-8","article-title":"Elective pelvic irradiation in stage A2, B carcinoma of the prostate: analysis of RTOG 77-06","volume":"15","author":"Asbell","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2018.04.009_bb0175","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.ijrobp.2004.08.047","article-title":"Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31","volume":"61","author":"Pilepich","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2018.04.009_bb0180","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1200\/JCO.2003.11.023","article-title":"Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group Protocol 92-02","volume":"21","author":"Hanks","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2018.04.009_bb0185","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(02)09408-4","article-title":"Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomised trial","volume":"360","author":"Bolla","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2018.04.009_bb0190","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/CIRCULATIONAHA.109.192695","article-title":"Androgen-deprivation therapy in prostate cancer and cardiovascular risk: A science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology","volume":"121","author":"Levine","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.prro.2018.04.009_bb0195","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1001\/jama.2009.1137","article-title":"Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction","volume":"302","author":"Nanda","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.prro.2018.04.009_bb0200","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/jnci\/djm168","article-title":"Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality","volume":"99","author":"Tsai","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.prro.2018.04.009_bb0205","doi-asserted-by":"crossref","first-page":"421","DOI":"10.6004\/jnccn.2016.0048","article-title":"Variation in national use of long-term ADT by disease aggressiveness among men with unfavorable-risk prostate cancer","volume":"14","author":"Muralidhar","year":"2016","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.prro.2018.04.009_bb0210","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.eururo.2016.02.057","article-title":"Assessment of the rate of adherence to international guidelines for androgen deprivation therapy with external-beam radiation therapy: A population-based study","volume":"70","author":"Dell'Oglio","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.prro.2018.04.009_bb0215","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/cncr.23228","article-title":"Racial disparities in cancer therapy: Did the gap narrow between 1992 and 2002?","volume":"112","author":"Gross","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2018.04.009_bb0220","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1200\/JCO.2007.13.2555","article-title":"Variations in quality of care for men with early-stage prostate cancer","volume":"26","author":"Spencer","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2018.04.009_bb0225","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1002\/cncr.28004","article-title":"Receipt of National Comprehensive Cancer Network guideline-concordant prostate cancer care among African American and Caucasian American men in North Carolina","volume":"119","author":"Ellis","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2018.04.009_bb0230","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","article-title":"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial","volume":"17","author":"Dearnaley","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2018.04.009_bb0235","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S1470-2045(16)30070-5","article-title":"Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): Final efficacy results from a randomised, multicentre, open-label, phase 3 trial","volume":"17","author":"Incrocci","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2018.04.009_bb0240","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1200\/JCO.2005.06.154","article-title":"Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate","volume":"23","author":"Sathya","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2018.04.009_bb0245","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2012.01.007","article-title":"Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer","volume":"103","author":"Hoskin","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2018.04.009_bb0250","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.mlr.0000196960.12860.de","article-title":"Comparison of administrative data and medical records to measure the quality of medical care provided to vulnerable older patients","volume":"44","author":"MacLean","year":"2006","journal-title":"Med Care"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850018301395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850018301395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:21:29Z","timestamp":1761819689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850018301395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1879850018301395"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2018.04.009","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contemporary prostate cancer radiation therapy in the United States: Patterns of care and compliance with quality measures","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2018.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}]}}